General Information of the Compound
| Compound ID |
CP0286510
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
6-(4-((1H-benzo[d]imidazol-2-yl)methyl)piperazin-1-yl)pyridin-3-ol
Show/Hide
|
||||||||||||||||||
| Synonyms |
6-[4-(1H-Benzoimidazole-2-ylmethyl)piperazino]-3-pyridinol
6-[4-(1H-benzimidazol-2-ylmethyl)piperazin-1-yl]pyridin-3-ol
A-425444
BDBM50200029
CBDXXUZXRDBOGH-UHFFFAOYSA-N
CHEMBL219179
LS-193223
SCHEMBL4809015
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H19N5O
|
||||||||||||||||||
| Molecular Weight |
309.373
|
||||||||||||||||||
| Canonical SMILES |
Oc1ccc(nc1)N1CCN(Cc2nc3ccccc3[nH]2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H19N5O/c23-13-5-6-17(18-11-13)22-9-7-21(8-10-22)12-16-19-14-3-1-2-4-15(14)20-16/h1-6,11,23H,7-10,12H2,(H,19,20)
Show/Hide
|
||||||||||||||||||
| InChIKey |
CBDXXUZXRDBOGH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound